news – Ophthalmological Society of Ghana https://osg-ghana.org Universal eye health for all Ghanaians Sat, 07 Sep 2024 08:44:29 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 2024 AGM and Scientific Conference https://osg-ghana.org/2024-agm-and-scientific-conference/ Sat, 17 Aug 2024 06:45:04 +0000 https://osg-ghana.org/?p=4001 more

]]>
Safety of intravitreal ziv-aflibercept in choroido-retinal vascular diseases: A randomised double-blind intervention study https://osg-ghana.org/safety-of-intravitreal-ziv-aflibercept-in-choroido-retinal-vascular-diseases-a-randomised-double-blind-intervention-study/ Sat, 26 Oct 2019 14:58:15 +0000 https://osg-ghana.org/?p=2337 more

]]>
Cardiovascular disease implicated in rapid glaucoma progression https://osg-ghana.org/cardiovascular-disease-implicated-in-rapid-glaucoma-progression/ https://osg-ghana.org/cardiovascular-disease-implicated-in-rapid-glaucoma-progression/#respond Tue, 07 Nov 2017 09:27:31 +0000 https://osg-ghana.org/?p=239 more

]]>
https://osg-ghana.org/cardiovascular-disease-implicated-in-rapid-glaucoma-progression/feed/ 0
Should we image all patients with third nerve palsy? https://osg-ghana.org/should-we-image-all-patients-with-third-nerve-palsy/ https://osg-ghana.org/should-we-image-all-patients-with-third-nerve-palsy/#respond Tue, 07 Nov 2017 09:22:34 +0000 https://osg-ghana.org/?p=235 more

]]>
https://osg-ghana.org/should-we-image-all-patients-with-third-nerve-palsy/feed/ 0
Discovery of new angiogenic factor may enhance treatment for retinal disease https://osg-ghana.org/discovery-of-new-angiogenic-factor-may-enhance-treatment-for-retinal-disease/ https://osg-ghana.org/discovery-of-new-angiogenic-factor-may-enhance-treatment-for-retinal-disease/#respond Tue, 07 Nov 2017 09:15:35 +0000 https://osg-ghana.org/?p=233 more

]]>
https://osg-ghana.org/discovery-of-new-angiogenic-factor-may-enhance-treatment-for-retinal-disease/feed/ 0
Low-cost ziv-aflibercept appears safe for intraocular administration https://osg-ghana.org/low-cost-ziv-aflibercept-appears-safe-for-intraocular-administration/ https://osg-ghana.org/low-cost-ziv-aflibercept-appears-safe-for-intraocular-administration/#respond Tue, 07 Nov 2017 09:11:17 +0000 https://osg-ghana.org/?p=231 more

]]>
https://osg-ghana.org/low-cost-ziv-aflibercept-appears-safe-for-intraocular-administration/feed/ 0
Telemedicine screening confirms acute ROP is typically symmetrical https://osg-ghana.org/telemedicine-screening-confirms-acute-rop-is-typically-symmetrical/ https://osg-ghana.org/telemedicine-screening-confirms-acute-rop-is-typically-symmetrical/#respond Tue, 07 Nov 2017 09:08:46 +0000 https://osg-ghana.org/?p=229 more

]]>
https://osg-ghana.org/telemedicine-screening-confirms-acute-rop-is-typically-symmetrical/feed/ 0
Early findings hint at safety, efficacy of stem-cell therapy for keratoconus https://osg-ghana.org/early-findings-hint-at-safety-efficacy-of-stem-cell-therapy-for-keratoconus/ https://osg-ghana.org/early-findings-hint-at-safety-efficacy-of-stem-cell-therapy-for-keratoconus/#respond Sun, 05 Nov 2017 19:18:22 +0000 https://osg-ghana.org/?p=179 more

]]>
https://osg-ghana.org/early-findings-hint-at-safety-efficacy-of-stem-cell-therapy-for-keratoconus/feed/ 0
Timing of IOL repositioning surgery significantly impacts refractive outcomes https://osg-ghana.org/timing-of-iol-repositioning-surgery-significantly-impacts-refractive-outcomes/ https://osg-ghana.org/timing-of-iol-repositioning-surgery-significantly-impacts-refractive-outcomes/#respond Fri, 03 Nov 2017 18:36:20 +0000 https://osg-ghana.org/?p=108 more

]]>
https://osg-ghana.org/timing-of-iol-repositioning-surgery-significantly-impacts-refractive-outcomes/feed/ 0
Injected mitomycin C offers advantages over standard application https://osg-ghana.org/injected-mitomycin-c-offers-advantages-over-standard-application/ https://osg-ghana.org/injected-mitomycin-c-offers-advantages-over-standard-application/#respond Fri, 03 Nov 2017 18:35:10 +0000 https://osg-ghana.org/?p=106 more

]]>
https://osg-ghana.org/injected-mitomycin-c-offers-advantages-over-standard-application/feed/ 0